0.00Open0.05Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV-79.84%PremiumJun 21, 2024Expiry Date10.15Intrinsic Value100Multiplier23DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma253.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Precision BioSciences Stock Discussion
Precision BioSciences Announces Common Stock Purchase By Members Of Management, Including CEO, For $300,000 In Private Placement
NEWS
PRECISION BIOSCIENCES ANNOUNCES COMMON STOCK PURCHASE BY MEMBERS OF MANAGEMENT FOR $300,000 IN A PRIVATE PLACEMENT
Precision BioSciences Announces Receipt of FDA Fast Track Designation for Ecur-506, Iecure’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (Otc) Deficiency
No comment yet